Sandul Amy L, Rapposelli Karina, Nyendak Melissa, Kim Min
Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC.
MMWR Morb Mortal Wkly Rep. 2024 Dec 5;73(48):1106. doi: 10.15585/mmwr.mm7348a3.
Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). The Advisory Committee on Immunization Practices recommends universal HepB vaccination for adults aged 19-59 years, including pregnant persons, and adults aged ≥60 years with risk factors for hepatitis B. Adults aged ≥60 years without known risk factors for hepatitis B may also receive HepB vaccines (2).
在过去40年中,乙肝(HepB)疫苗已证明具有安全性、免疫原性和有效性(1,2)。免疫实践咨询委员会建议,19至59岁的成年人,包括孕妇,以及≥60岁且有乙肝危险因素的成年人普遍接种乙肝疫苗。≥60岁且无已知乙肝危险因素的成年人也可接种乙肝疫苗(2)。